253 related articles for article (PubMed ID: 10026909)
1. Development of a double-copy bicistronic retroviral vector for human gene therapy.
Wiznerowicz M; Fong AZ; Hawley RG; Mackiewicz A
Adv Exp Med Biol; 1998; 451():441-7. PubMed ID: 10026909
[No Abstract] [Full Text] [Related]
2. Retroviral transfer of the nlsLacZ gene into human CD34+ cell populations and into TF-1 cells: future prospects in gene therapy.
Bagnis C; Gravis G; Imbert AM; Herrera D; Allario T; Galindo R; Lopez M; Pavon C; Sempere C; Mannoni P
Hum Gene Ther; 1994 Nov; 5(11):1325-33. PubMed ID: 7534481
[TBL] [Abstract][Full Text] [Related]
3. Efficient gene transfer in mouse neural precursors with a bicistronic retroviral vector.
Franceschini IA; Feigenbaum-Lacombe V; Casanova P; Lopez-Lastra M; Darlix JL; Dalcq MD
J Neurosci Res; 2001 Aug; 65(3):208-19. PubMed ID: 11494355
[TBL] [Abstract][Full Text] [Related]
4. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.
Yee JK; Miyanohara A; LaPorte P; Bouic K; Burns JC; Friedmann T
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9564-8. PubMed ID: 7937806
[TBL] [Abstract][Full Text] [Related]
5. n beta geo, a combined selection and reporter gene for retroviral and transgenic studies.
Blake J; Salinas PC; Hughes SM
Biotechniques; 1997 Oct; 23(4):690-5. PubMed ID: 9343694
[TBL] [Abstract][Full Text] [Related]
6. Retroviral gene transfer in mice: the use of a unique packaging line improves efficiency.
Hesdorffer CS; Markowitz D; Ward M; Lerner NB; Bank A
Adv Exp Med Biol; 1989; 271():149-60. PubMed ID: 2486281
[No Abstract] [Full Text] [Related]
7. Retroviral vector-mediated gene expression in human CD34+CD38- cells expanded in vitro: cis elements of FMEV are superior to those of Mo-MuLV.
Tsuji T; Itoh K; Baum C; Ohnishi N; Tomiwa K; Hirano D; Nishimura-Morita Y; Ostertag W; Fujita J
Hum Gene Ther; 2000 Jan; 11(2):271-84. PubMed ID: 10680841
[TBL] [Abstract][Full Text] [Related]
8. In vivo infection of mice by replication-competent MLV-based retroviral vectors.
Bachrach E; Duch M; Pelegrin M; Dreja H; Pedersen FS; Piechaczyk M
Methods Mol Med; 2003; 76():343-52. PubMed ID: 12526173
[No Abstract] [Full Text] [Related]
9. Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
Reeves L; Duffy L; Koop S; Fyffe J; Cornetta K
Hum Gene Ther; 2002 Sep; 13(14):1783-90. PubMed ID: 12396630
[TBL] [Abstract][Full Text] [Related]
10. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
11. Transgene inheritance and retroviral infection contribute to the efficiency of gene expression in solid tumors inoculated with retroviral vector producer cells.
Tamiya T; Wei MX; Chase M; Ono Y; Lee F; Breakefield XO; Chiocca EA
Gene Ther; 1995 Oct; 2(8):531-8. PubMed ID: 8593603
[TBL] [Abstract][Full Text] [Related]
12. Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood.
Campain JA; Terrell KL; Tomczak JA; Shpall EJ; Hami LS; Harrison GS
Biol Blood Marrow Transplant; 1997 Nov; 3(5):273-81. PubMed ID: 9450923
[TBL] [Abstract][Full Text] [Related]
13. Plasmoviruses: nonviral/viral vectors for gene therapy.
Noguiez-Hellin P; Meur MR; Salzmann JL; Klatzmann D
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4175-80. PubMed ID: 8633036
[TBL] [Abstract][Full Text] [Related]
14. Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells.
Oshiro EM; Viola JJ; Oldfield EH; Walbridge S; Bacher J; Frank JA; Blaese RM; Ram Z
Cancer Gene Ther; 1995 Jun; 2(2):87-95. PubMed ID: 7621261
[TBL] [Abstract][Full Text] [Related]
15. Development of a condensed locus control region cassette and testing in retrovirus vectors for A gamma-globin.
Emery DW; Chen H; Li Q; Stamatoyannopoulos G
Blood Cells Mol Dis; 1998 Sep; 24(3):322-39. PubMed ID: 10087991
[TBL] [Abstract][Full Text] [Related]
16. Pantropic retroviral vector integration, expression, and germline transmission in medaka (Oryzias latipes).
Lu JK; Burns JC; Chen TT
Mol Mar Biol Biotechnol; 1997 Dec; 6(4):289-95. PubMed ID: 9418287
[TBL] [Abstract][Full Text] [Related]
17. Assembly of gag-beta-galactosidase proteins into retrovirus particles.
Jones TA; Blaug G; Hansen M; Barklis E
J Virol; 1990 May; 64(5):2265-79. PubMed ID: 2109101
[TBL] [Abstract][Full Text] [Related]
18. Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells.
Friedrich G; Soriano P
Methods Enzymol; 1993; 225():681-701. PubMed ID: 8231879
[No Abstract] [Full Text] [Related]
19. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
[TBL] [Abstract][Full Text] [Related]
20. Q vectors, bicistronic retroviral vectors for gene transfer.
Julius MA; Yan Q; Zheng Z; Kitajewski J
Biotechniques; 2000 Apr; 28(4):702-8. PubMed ID: 10769748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
